###begin article-title 0
###xml 42 44 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 201 205 <span type="species:ncbi:10116">rats</span>
Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 87 89 87 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 163 167 <span type="species:ncbi:10116">rats</span>
###xml 175 179 <span type="species:ncbi:10116">rats</span>
this study set out to examine the effects of the treatment with 1,25-dihydroxyvitamin D3 (1,25D3) [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] to non-diabetic rats and in rats rendered diabetic by a single injection of streptozotocin [65 mg/kg].
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 334 336 334 336 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 371 375 <span type="species:ncbi:10116">rats</span>
###xml 911 914 <span type="species:ncbi:10116">rat</span>
treatment with 1,25D3 to non-diabetic rats did not affect the biochemical parameters measured in the plasma and urine of these animals. Likewise, insulin receptor expression in the kidney, liver, or adipose tissue and insulin-stimulated glucose transport in adipocytes from these animals were not affected either. Treatment with 1,25D3 to streptozotocin-induced diabetic rats did not correct the hyperglycemia, hypoinsulinemia, glycosuria or ketonemia induced by the diabetes, although it partially reversed the over-expression of the insulin receptor gene in the liver and adipose tissue, without altering the normal expression of this gene in the kidney. These effects were accompanied by a normalization of the number of insulin receptors without altering receptor affinity but improving the insulin response to glucose transport in adipocytes from these diabetic animals. Moreover, a computer search in the rat insulin receptor promoter revealed the existence of two candidate vitamin D response element (VDRE) sequences located at -256/-219 bp and -653/-620 bp, the first overlapped by three and the second by four AP-2-like sites.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 30 32 30 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 268 270 268 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 190 193 <span type="species:ncbi:10116">rat</span>
these genomic actions of 1,25D3 could represent beneficial effects associated with the amelioration of diabetes via mechanisms that possibly involve direct transcriptional activation of the rat insulin receptor gene. The candidate VDREs identified may respond to 1,25D3 via activation of the vitamin D receptor, although this remains to be investigated.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 90 92 90 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 98 99 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 213 214 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 374 375 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 428 430 428 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 637 642 637 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 642 644 642 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 840 841 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 249 252 <span type="species:ncbi:10116">rat</span>
###xml 654 659 <span type="species:ncbi:9606">human</span>
###xml 725 730 <span type="species:ncbi:9606">human</span>
###xml 823 828 <span type="species:ncbi:9606">human</span>
It is known that vitamin D and especially its activated metabolite 1,25-dihydroxyvitamin D3 (1,25D3), are involved in controlling the normal function of the endocrine pancreas, and particularly insulin secretion [1,2]. Vitamin D deficiency inhibits rat pancreatic secretion and turnover of insulin, leading to impaired glucose tolerance, while replacement therapy with 1,25D3, is able to reverse these abnormalities [3,4]. 1,25D3 also affects the insulin receptor (IR), the protein to which insulin must bind to carry out its multiple biological actions in the cells. In this respect, our group has reported the first demonstration that 1,25D3 increased human IR mRNA levels, the IR number, and the insulin response in U-937 human promonocytic cells through mechanisms that involve direct transcriptional activation of the human IR gene [5-7].
###end p 9
###begin p 10
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 119 121 119 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 215 216 215 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 538 540 538 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 835 837 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1000 1002 1000 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1162 1164 1162 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1224 1226 1224 1226 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1348 1350 1348 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 22 26 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 164 168 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 1110 1114 <span type="species:ncbi:10116">rats</span>
In non-obese diabetic mice, vitamin D deficiency accelerates type 1 diabetes [8], while chronic administration of 1,25D3 reduces the incidence of diabetes in these mice, principally by modulating immune mechanisms [9-11]. Streptozotocin-induced diabetes is another animal model of diabetes that comprises both toxic and inflammatory mechanisms [12]. Mononuclear infiltration and the altered morphology of islets coupled with the disappearance of beta cells are among the histological changes reported in the pancreas of these animals [12,13]. Indeed, hyperglycemia and hypoinsulinemia, have also been described in this experimental model [14,15]. This hypoinsulinemia was associated with increased insulin binding in the kidney [16,17] and liver [14,18] and with somewhat controversial insulin binding results in adipose tissue [15,19,20]. The increases in renal and hepatic IRs, were accompanied by elevated IR mRNA expression in both tissues, and it could be reversed by treatment with insulin [21-23]. Despite the different alterations in IR mRNA levels and insulin binding, streptozotocin-induced diabetic rats characteristically display insulin resistance [15,18,19]. In this diabetic model, the administration of 1,25D3 for 8 weeks was reported to improve diabetes attenuating pancreatic islet damage and decreasing the insulin requirements [12].
###end p 10
###begin p 11
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 5 7 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 948 950 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 951 953 951 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1126 1128 1126 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1201 1206 1201 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 1206 1208 1206 1208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1230 1231 1230 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1232 1234 1232 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1102 1107 <span type="species:ncbi:9606">human</span>
###xml 1217 1222 <span type="species:ncbi:9606">human</span>
1,25D3 acts in its genomic effects as a ligand for the vitamin D receptor (VDR, NR1I1) [24]. This receptor is a member of the superfamily of nuclear receptors that regulates gene expression as a vitamin D-dependent transcription factor. It exerts this action by binding, preferentially as a heterodimer with the retinoid x receptor (RXR), to vitamin D response elements (VDREs) in the promoter regions of target genes [25]. A VDRE generally consists of two direct imperfect repeats of six nucleotides separated by a three-nucleotide spacer. The VDR occupies the 3' half-site, while the RXR binds to the 5' half-site [26]. Sequence variations have been detected in the 3' half-element, the 5' half-element, the spacer, and in the sequences flanking the VDREs and these variations appear to be important in receptor-binding efficiency [27,28]. The identification of VDREs has only been possible in a very limited number of vitamin D-regulated genes [26,27]. Our group has reported the first identification of a functional VDRE overlapped by a downstream AP-2-like site that specifically binds VDR in the human IR gene promoter [29]. This VDRE accounted for the transcriptional induction of this gene by 1,25D3 in U-937 human cells [7,29].
###end p 11
###begin p 12
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 113 115 113 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 270 275 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 275 277 274 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1101 1106 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 1106 1108 1105 1107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 216 220 <span type="species:ncbi:10116">rats</span>
###xml 319 323 <span type="species:ncbi:10116">rats</span>
###xml 379 383 <span type="species:ncbi:10116">rats</span>
###xml 852 855 <span type="species:ncbi:10116">rat</span>
With these antecedents, the aim of the present investigation was to study the effects of the treatment with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] to non-diabetic and streptozotocin-induced diabetic rats. The results indicated that while treatment with 1,25D3 had practically no effect on non-diabetic rats, the same treatment in streptozotocin-induced diabetic rats corrected in part the over-expression of the IR gene in liver and adipose tissue, although it did not revert the hyperglycemia, hypoinsulinemia, glycosuria or ketonemia of these diabetic animals. At the same time, it produced normalization of the IR number without alterations in the receptor affinity and with an improvement of the insulin response in terms of glucose transport in isolated adipocytes of these diabetic animals. In addition, a computer search in the rat insulin receptor gene promoter revealed the existence of two DNA sequences: -256/-219 bp and -653/-620 bp, the first overlapped by three and the second by four AP-2-like sites. These sequences represent two candidate VDREs that could respond to 1,25D3 via activation of VDR, although this remains to be further investigated.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 71 72 71 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Body weights and plasma values of glucose, insulin, 25-hidroxyvitamin D3, calcium, phosphorus and proteins
###end title 14
###begin p 15
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 279 281 279 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 528 530 528 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 567 569 567 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 578 579 578 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 57 60 <span type="species:ncbi:10116">rat</span>
###xml 316 320 <span type="species:ncbi:10116">rats</span>
Treatment with 1,25D3 to non-diabetic rats increased the rat body weights but did not affect any parameter in the plasma of these animals (Table 1). The injection of streptozotocin reduced body weights and induced hyperglycemia and hypoinsulinemia (Table 1). Treatment with 1,25D3 to streptozotocin-induced diabetic rats increased body weights but did not revert the hyperglycemia and the hypoinsulinemia induced by the diabetes, while calcium and phosphorus plasma levels were increased and plasma levels of 25-hydroxyvitamin D3 were maintained in the normal range [30] (Table 1).
###end p 15
###begin p 16
###xml 53 57 <span type="species:ncbi:10116">rats</span>
Body weights and plasma values of the four groups of rats under study
###end p 16
###begin p 17
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 52 54 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 104 109 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 109 110 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 151 154 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 210 215 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 215 217 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 218 227 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ+1,25D</italic>
###xml 227 228 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 13 17 <span type="species:ncbi:10116">rats</span>
###xml 29 33 <span type="species:ncbi:10116">rats</span>
###xml 145 149 <span type="species:ncbi:10116">rats</span>
###xml 151 154 <span type="species:ncbi:10116">STZ</span>
###xml 192 196 <span type="species:ncbi:10116">rats</span>
###xml 218 221 <span type="species:ncbi:10116">STZ</span>
Sham-treated rats (Control), rats treated with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] (1,25D3), streptozotocin-induced diabetic rats (STZ) and streptozotocin-induced diabetic rats treated with 1,25D3 (STZ+1,25D3).
###end p 17
###begin p 18
Values are the mean +/- SEM of 6-12 determinations in each group.
###end p 18
###begin p 19
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 23 27 <span type="species:ncbi:10116">rats</span>
###xml 51 55 <span type="species:ncbi:10116">rats</span>
###xml 72 75 <span type="species:ncbi:10116">STZ</span>
###xml 76 80 <span type="species:ncbi:10116">rats</span>
a p < 0.05 vs. Control-rats; b p < 0.05 vs. 1,25D3-rats; c p < 0.05 vs. STZ-rats.
###end p 19
###begin title 20
Values of specific gravity, pH, leukocytes, nitrite, protein, glucose, ketones, urobilinogen, bilirubin and blood in urine
###end title 20
###begin p 21
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 267 272 267 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 272 273 272 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 308 312 <span type="species:ncbi:10116">rats</span>
Treatment with 1,25D3 to non-diabetic rats did not affect any of the above cited urine parameters under study. Streptozotocin injection induced glycosuria (> 500 mg/dl) and the appearance of leukocytes, ketones and blood in the urine of these animals. Treatment with 1,25D3to streptozotocin-induced diabetic rats did not modify the glycosuria and the ketonuria of the diabetes, but partially decreased the number of leukocytes in urine (from 10-25 to 5-10 leukocytes/mul).
###end p 21
###begin title 22
Total DNA, RNA and protein content of the kidney, liver and epididymal adipose tissue
###end title 22
###begin p 23
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 480 485 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 485 487 485 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 522 526 <span type="species:ncbi:10116">rats</span>
Treatment with 1,25D3 to non-diabetic rats increased both the protein content and the indicator of cell size (protein/DNA) in the kidney, liver and adipose tissue of these animals while the DNA and RNA content remained unaltered (Table 2). Streptozotocin injection incremented the protein content in these three tissues, accompanied in the case of kidney with an increment of the protein/DNA ratio and in the case of the liver with an increment of the DNA content. Treatment with 1,25D3 of streptozotocin-induced diabetic rats practically did not modify neither the high values of protein induced by the diabetes in the three tissues nor the increases in the DNA content in kidney and liver. In addition, this treatment did not alter the RNA content in any of these three tissues (Table 2).
###end p 23
###begin p 24
###xml 80 84 <span type="species:ncbi:10116">rats</span>
Total DNA, RNA and protein content in different tissues from the four groups of rats
###end p 24
###begin p 25
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 52 54 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 104 109 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 109 110 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 151 154 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 210 215 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 215 217 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 218 227 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ+1,25D</italic>
###xml 227 228 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 13 17 <span type="species:ncbi:10116">rats</span>
###xml 29 33 <span type="species:ncbi:10116">rats</span>
###xml 145 149 <span type="species:ncbi:10116">rats</span>
###xml 151 154 <span type="species:ncbi:10116">STZ</span>
###xml 192 196 <span type="species:ncbi:10116">rats</span>
###xml 218 221 <span type="species:ncbi:10116">STZ</span>
Sham-treated rats (Control), rats treated with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] (1,25D3), streptozotocin-induced diabetic rats (STZ) and streptozotocin-induced diabetic rats treated with 1,25D3 (STZ+1,25D3).
###end p 25
###begin p 26
Values are the mean +/- SEM of 4-6 determinations in each group.
###end p 26
###begin p 27
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 23 27 <span type="species:ncbi:10116">rats</span>
###xml 51 55 <span type="species:ncbi:10116">rats</span>
###xml 72 75 <span type="species:ncbi:10116">STZ</span>
###xml 76 80 <span type="species:ncbi:10116">rats</span>
a p < 0.05 vs. Control-rats; b p < 0.05 vs. 1,25D3-rats; c p < 0.05 vs. STZ-rats.
###end p 27
###begin title 28
Insulin receptor mRNA levels in the kidney, liver and epididymal adipose tissue
###end title 28
###begin p 29
###xml 39 40 39 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 73 74 73 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 427 432 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 432 434 426 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 545 546 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 645 646 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 668 673 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 673 675 667 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1050 1051 1044 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1177 1178 1171 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1205 1210 1199 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 1210 1212 1204 1206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1305 1306 1299 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1351 1352 1345 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1513 1518 1507 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 1518 1520 1512 1514 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1584 1585 1578 1579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 450 454 <span type="species:ncbi:10116">rats</span>
###xml 709 713 <span type="species:ncbi:10116">rats</span>
###xml 1224 1228 <span type="species:ncbi:10116">rats</span>
###xml 1532 1536 <span type="species:ncbi:10116">rats</span>
Northern blot assays of kidney (Figure 1, panels A and B), liver (Figure 1, panels C and D) and epididymal adipose tissue (Figure 1, panels E and F) from control animals revealed two major IR mRNA species of approximately 9.5 and 7.5 Kb in size. The relative amounts of the two IR mRNA species measured as 9.5 Kb/7.5 Kb ratio were: 2.2 +/- 0.2 in kidney, 1.2 +/- 0.2 in liver and 1.1 +/- 0.03 in adipose tissue. Treatment with 1,25D3 to non-diabetic rats did not affect any of the two IR mRNA species in any of the three tissues studied (Figure 1, panels A to F). IR mRNA species were expressed per unit of RNA in view of the observation (Table 2) that treatment with 1,25D3 to both non-diabetic and diabetic rats did not alter RNA content per gram of tissue in any of the three tissues. The induction of diabetes by streptozotocin produced important increments in the levels of both IR mRNA species in liver and adipose tissue but not in kidney. In particular, 78% increase corresponding to the 9.5 Kb and 69% to the 7.5 Kb species in liver (Figure 1, panel D), and 58% increase corresponding to the 9.5 Kb and 92% increase to the 7.5 Kb species in the adipose tissue (Figure 1, panel F). Treatment with 1,25D3 to diabetic rats partially prevented the over-expression of the IR mRNA in the liver (Figure 1, panels C and D) and adipose tissue (Figure 1, panels E and F) of these animals. The 9.5 Kb species was particularly decreased in liver and the 7.5 kb species in the adipose tissue. However, treatment with 1,25D3 to diabetic rats did not affect IR expression in kidney (Figure 1, panels A and B).
###end p 29
###begin p 30
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Renal, hepatic and adipose IR mRNA levels</bold>
###xml 171 178 171 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 199 204 199 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 204 206 204 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 255 260 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 260 261 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 302 305 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 361 366 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 366 368 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 369 372 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 373 378 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 378 379 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 890 897 889 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 919 921 916 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 934 941 931 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 948 950 945 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 963 968 960 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 968 969 965 966 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 980 982 977 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 995 998 992 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 165 169 <span type="species:ncbi:10116">rats</span>
###xml 181 185 <span type="species:ncbi:10116">rats</span>
###xml 296 300 <span type="species:ncbi:10116">rats</span>
###xml 302 305 <span type="species:ncbi:10116">STZ</span>
###xml 343 347 <span type="species:ncbi:10116">rats</span>
###xml 369 372 <span type="species:ncbi:10116">STZ</span>
###xml 522 526 <span type="species:ncbi:10116">rats</span>
###xml 898 902 <span type="species:ncbi:10116">rats</span>
###xml 942 946 <span type="species:ncbi:10116">rats</span>
###xml 970 974 <span type="species:ncbi:10116">rats</span>
###xml 995 998 <span type="species:ncbi:10116">STZ</span>
###xml 999 1003 <span type="species:ncbi:10116">rats</span>
Renal, hepatic and adipose IR mRNA levels. Insulin receptor (IR) mRNA levels in the kidney (A, B), liver (C, D) and epididymal adipose tissue (E, F) of sham-treated rats (Control), rats treated with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days](1,25D3), streptozotocin-induced diabetic rats (STZ) and streptozotocin-induced diabetic rats treated with 1,25D3 (STZ+1,25D3). On the right, the autoradiograph of a representative Northern blot experiment using the kidney (B), liver (D) and adipose tissue (F) of two rats. The sizes of the two major IR mRNA species are shown in the margin. On the left, densitometric analysis of three independent Northern blot experiments on kidney (A), liver (C), and adipose tissue (E). IR mRNA species were quantified separately, normalized to the respective 28S rRNA values and expressed per unit of RNA as a percentage of the values obtained in Control-rats (mean +/- SEM). a p < 0.05 vs. Control-rats; b p < 0.05 vs. 1,25D3-rats; and c p < 0.05 vs. STZ-rats.
###end p 30
###begin title 31
Insulin binding in isolated adipocytes
###end title 31
###begin p 32
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 56 58 56 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 325 327 325 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 563 564 563 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 74 78 <span type="species:ncbi:10116">rats</span>
###xml 362 366 <span type="species:ncbi:10116">rats</span>
Insulin binding studies showed that treatment with 1,25D3 to non-diabetic rats did not alter IR number or IR affinity as reflected by the ED:50 value in adipocytes of these animals (Figure 2 and Table 3). Streptozotocin injection produced a 64% decrease in the number of IRs without altering IR affinity. Treatment with 1,25D3 to streptozotocin-induced diabetic rats inverted the decrease in the IR number induced by the diabetes to values not significantly different from those observed in control adipocytes and without altering IR affinity (Figure 2 and Table 3).
###end p 32
###begin p 33
###xml 76 80 <span type="species:ncbi:10116">rats</span>
Insulin binding parameters in epididymal adipocytes from the four groups of rats
###end p 33
###begin p 34
###xml 19 26 19 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 52 54 52 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 104 109 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 109 110 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 151 154 150 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 210 215 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 215 217 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 218 227 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ+1,25D</italic>
###xml 227 228 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 13 17 <span type="species:ncbi:10116">rats</span>
###xml 29 33 <span type="species:ncbi:10116">rats</span>
###xml 145 149 <span type="species:ncbi:10116">rats</span>
###xml 151 154 <span type="species:ncbi:10116">STZ</span>
###xml 192 196 <span type="species:ncbi:10116">rats</span>
###xml 218 221 <span type="species:ncbi:10116">STZ</span>
Sham-treated rats (Control), rats treated with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] (1,25D3), streptozotocin-induced diabetic rats (STZ) and streptozotocin-induced diabetic rats treated with 1,25D3 (STZ+1,25D3).
###end p 34
###begin p 35
Values are the mean +/- SEM of 3-9 determinations in each group.
###end p 35
###begin p 36
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 15 22 15 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 23 27 <span type="species:ncbi:10116">rats</span>
###xml 51 55 <span type="species:ncbi:10116">rats</span>
###xml 72 75 <span type="species:ncbi:10116">STZ</span>
###xml 76 80 <span type="species:ncbi:10116">rats</span>
a p < 0.05 vs. Control-rats; b p < 0.05 vs. 1,25D3-rats; c p < 0.05 vs. STZ-rats.
###end p 36
###begin p 37
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Insulin receptor number per cell</bold>
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 140 142 140 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 192 197 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 197 198 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 239 242 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 298 303 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 303 305 302 304 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 306 309 305 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 310 315 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 315 316 314 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 384 386 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 399 406 396 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 413 415 410 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 428 433 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 433 434 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 445 447 442 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 460 463 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 101 105 <span type="species:ncbi:10116">rats</span>
###xml 117 121 <span type="species:ncbi:10116">rats</span>
###xml 233 237 <span type="species:ncbi:10116">rats</span>
###xml 239 242 <span type="species:ncbi:10116">STZ</span>
###xml 280 284 <span type="species:ncbi:10116">rats</span>
###xml 306 309 <span type="species:ncbi:10116">STZ</span>
###xml 407 411 <span type="species:ncbi:10116">rats</span>
###xml 435 439 <span type="species:ncbi:10116">rats</span>
###xml 460 463 <span type="species:ncbi:10116">STZ</span>
###xml 464 468 <span type="species:ncbi:10116">rats</span>
Insulin receptor number per cell. Insulin receptor number in epididymal adipocytes from sham-treated rats (Control), rats treated with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] (1,25D3), streptozotocin-induced diabetic rats (STZ) and streptozotocin-induced diabetic rats treated with 1,25D3 (STZ+1,25D3). Values are the mean +/- SEM of 3-9 determinations in each group. a p < 0.05 vs. Control-rats; b p < 0.05 vs. 1,25D3-rats; and c p < 0.05 vs. STZ-rats.
###end p 37
###begin p 38
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 194 195 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 318 323 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 323 325 322 324 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 376 377 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
Given that both the weight of the adipose tissue and the diameter of the adipocytes were markedly decreased by the diabetes (Table 3), we also calculated the IR number per cell surface area (mum2). In these conditions, although the effect of the diabetes decreasing IR number was somewhat minor (44%), the tendency of 1,25D3 to normalize the IR number was also evident (Table 3).
###end p 38
###begin title 39
Glucose transport in isolated adipocytes
###end title 39
###begin p 40
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 275 277 275 277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 312 316 <span type="species:ncbi:10116">rats</span>
Treatment with 1,25D3 to non-diabetic rats did not alter basal or insulin-stimulated glucose transport in adipocytes from these animals (Figure 3). The injection of streptozotocin clearly decreased both basal and insulin-stimulated glucose transport. The treatment with 1,25D3 to streptozotocin-induced diabetic rats, improved by 107% the decreased basal glucose transport and by 71% the insulin-stimulated glucose transport in adipocytes from these diabetic animals (Figure 3).
###end p 40
###begin p 41
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Basal and insulin stimulated glucose transport</bold>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 177 179 177 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 229 234 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 234 235 233 234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 276 279 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 335 340 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 340 342 339 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 343 346 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 347 352 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 352 353 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 425 427 422 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 440 447 437 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control</italic>
###xml 454 456 451 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
###xml 469 474 466 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 474 475 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 486 488 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c </sup>
###xml 501 504 498 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 138 142 <span type="species:ncbi:10116">rats</span>
###xml 154 158 <span type="species:ncbi:10116">rats</span>
###xml 270 274 <span type="species:ncbi:10116">rats</span>
###xml 276 279 <span type="species:ncbi:10116">STZ</span>
###xml 317 321 <span type="species:ncbi:10116">rats</span>
###xml 343 346 <span type="species:ncbi:10116">STZ</span>
###xml 448 452 <span type="species:ncbi:10116">rats</span>
###xml 476 480 <span type="species:ncbi:10116">rats</span>
###xml 501 504 <span type="species:ncbi:10116">STZ</span>
###xml 505 509 <span type="species:ncbi:10116">rats</span>
Basal and insulin stimulated glucose transport. Basal and insulin stimulated glucose transport in epididymal adipocytes from sham-treated rats (Control), rats treated with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] (1,25D3), streptozotocin-induced diabetic rats (STZ) and streptozotocin-induced diabetic rats treated with 1,25D3 (STZ+1,25D3). Values are the mean +/- SEM of 6-7 determinations within each group. a p < 0.05 vs. Control-rats; b p < 0.05 vs. 1,25D3-rats; and c p < 0.05 vs. STZ-rats.
###end p 41
###begin title 42
###xml 42 45 <span type="species:ncbi:10116">rat</span>
Computer analysis of DNA sequences in the rat IR gene promoter
###end title 42
###begin p 43
###xml 106 116 106 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 142 152 142 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 155 161 155 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GGGTCA</bold>
###xml 164 170 164 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GGGGCA</bold>
###xml 286 287 286 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 342 352 342 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 578 587 578 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus</italic>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 750 759 750 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus</italic>
###xml 882 883 882 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 64 67 <span type="species:ncbi:10116">rat</span>
We performed a computer search of virtual VDRE sequences in the rat IR gene promoter by homology with two consensus VDRE sequences. The first consensus (5'GGGTCANNGGGGGCA3') was previously compiled and reported by us from a series of described functional VDRE sequences in various 1,25D3-stimulated promoters [29]. The search with this first consensus indicated no sequence identical to this VDRE sequence, and neither was any sequence found to show 1, 2, or 3 base variations. Nevertheless, we detected three virtual VDRE sequences showing a difference of four bases from this consensus: -249/-235, -637/-623 and -916/-902 (Figure 4, panel A). Comparison of the 3' half-element of each of these sequences with the 3' half-element of this first VDRE consensus, indicated complete homology only in the case of the -916/-902 sequence, and two base variations in the other two (Figure 4, panel A).
###end p 43
###begin p 44
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Panel A: Computer search of vitamin D response elements (VDREs) in the rat insulin receptor (IR) gene promoter</bold>
###xml 208 218 208 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 330 340 330 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 420 430 420 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 659 669 659 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 795 804 795 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus</italic>
###xml 948 958 948 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 1149 1159 1132 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 1239 1249 1222 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 71 74 <span type="species:ncbi:10116">rat</span>
###xml 144 147 <span type="species:ncbi:10116">rat</span>
###xml 516 519 <span type="species:ncbi:10116">rat</span>
###xml 590 593 <span type="species:ncbi:10116">rat</span>
###xml 1073 1076 <span type="species:ncbi:10116">rat</span>
Panel A: Computer search of vitamin D response elements (VDREs) in the rat insulin receptor (IR) gene promoter. Potential VDRE sequences in the rat IR gene promoter were identified by their homology with two consensus VDRE sequences using the SEQFIND programme developed in our laboratory. Nucleotides identical to the first VDRE consensus are labelled by filled circles (●) and nucleotides identical to the second VDRE consensus are labelled by empty circles (o). Panel B: Computer search of AP-2-like sites in the rat insulin receptor (IR) gene promoter. Potential AP-2-like sites in the rat IR gene promoter were identified by their homology with the AP-2 consensus (5'GCCN3GGG3') [32] using the SEQFIND programme. We detected 17 AP-2-like sites showing a difference of only 1 base from this consensus. Of these, only 7 AP-2-like sites flanking or overlapping the potential VDRE sequences in panel A are shown. Nucleotides identical to the AP-2 consensus are labelled by stars (small star, filled). Panel C: Candidate VDRE sequences overlapped by AP-2-like sites in the rat insulin receptor gene promoter. Nucleotides identical to the first VDRE consensus are labelled by filled circles (●) and nucleotides identical to the second VDRE consensus are labelled by empty circles (o)
###end p 44
###begin p 45
###xml 77 87 77 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 104 111 104 111 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PuGGTCA</bold>
###xml 115 122 115 122 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PuGTTCA</bold>
###xml 151 161 151 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 221 228 221 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 502 512 502 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 736 745 736 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus</italic>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 913 923 913 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 931 932 931 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1076 1077 1076 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1159 1160 1159 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
The second computer search of virtual VDREs, now by homology with the second consensus VDRE sequence (5'PuGGTCANNPuPuGTTCA3'), was also performed. Our consensus and the latter proposed by Colnot et al. [27], and Haussler et al. [26] have identical 5' half-elements, but ours contains two GG instead of two TT, in the 3' half-element. The spacers are identical, with a G or Pu at position 3, which appears to be important in VDR binding. The results of this computer search by homology with this second consensus indicated no sequence identical to this VDRE, and neither was any sequence found to show 1, 2, or 3 base variations. Nevertheless, we detected three virtual VDRE sequences showing a difference of four bases from this second consensus: -25/-11, -247/-233 and -881/-867 (Figure 4, panel A). Of these, the -247/-233 sequence was in part the same as that of the -249/-235 sequence detected with the first consensus (Figure 4, panel A). However, the 3' half-element of this second sequence has only one base variation instead of two that the first sequence had (Figure 4, panel A). Therefore, in principle there were six virtual VDRE sequences (Figure 4, panel A).
###end p 45
###begin p 46
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 110 113 <span type="species:ncbi:10116">rat</span>
The next step was to check for the possibility of cis-elements related to these virtual VDRE sequences in the rat IR gene promoter. Thus, a computer search of AP-1 and AP-2 sites by homology with the AP-1 site consensus (5'TGAC/GTCA3') [31], and the AP-2 site consensus (5'GCCN3GGG3') [32], respectively, was performed.
###end p 46
###begin p 47
###xml 508 517 508 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus</italic>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 897 898 897 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1084 1085 1084 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1167 1168 1167 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1241 1242 1241 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1319 1320 1319 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1344 1354 1344 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in tandem </italic>
###xml 1417 1418 1417 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 368 371 <span type="species:ncbi:10116">rat</span>
Exploring the AP-1 sites, we detected two AP-1-like sites showing a difference of only one base from this consensus: the -374/-368 (5'TGTCTCA3') and the -963/-957 (5'TGAGCCA3'). However, these two sites are neither adjacent nor overlapped in any of our virtual VDRE sequences. Nevertheless, as far as we know, this is the first mention of these AP-1-like sites in the rat IR gene promoter. With respect to the AP-2 sites, we detected seventeen AP-2-like sites showing a difference of only one base from this consensus: -71/-63, -79/-71, -171/-163, -195/-187, -230/-222, -245/-237, -253/-245, -405/-397, -465/-457, -480/-472, -545/-537, -634/-626, -635/-627, -642/-634, -650/-642, -1087/-1079, -1088/-1080. Of these AP-2-like sites, only seven are included in panel B of the Figure 4. These were those flanking or overlapping some of the potential VDRE sequences indicated in panel A of the Figure 4. Of them, the -230/-222 (1) was located downstream, and the -245/-237 (2) and the -253/-245 (3) were overlapping the virtual VDRE sequences: -249/-235 and -247/-233, as shown in Figure 4, panel C. Moreover, the AP-2-like sites: -634/-626 (4) and -635/-627 (5) (Figure 4, panel B) were overlapping the virtual VDRE sequence: -637/-623 (Figure 4, panel C), and the AP-2-like sites: -642/-634 (6) and -650/-642 (7) (Figure 4, panel B) were located in tandem upstream of this last virtual VDRE sequence: -637/-623 (Figure 4, panel C).
###end p 47
###begin p 48
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 241 244 <span type="species:ncbi:10116">rat</span>
Therefore, we postulate as candidate VDRE sequences overlapped by AP-2-like sites those represented in Figure 4, panel C. One, located between -256 and -219 bp with three AP-2-like sites, and the other extending from -653 and -620 bp of the rat IR gene promoter with four AP-2-like sites. Separately or together, these VDRE sequences could form a locus that may respond to 1,25D3 via activation of VDR.
###end p 48
###begin title 49
Discussion
###end title 49
###begin title 50
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 31 33 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 49 53 <span type="species:ncbi:10116">rats</span>
Effects of treatment with 1,25D3 to non-diabetic rats
###end title 50
###begin p 51
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 384 386 384 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 467 469 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 651 653 651 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 866 868 866 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 426 431 <span type="species:ncbi:9606">human</span>
###xml 638 643 <span type="species:ncbi:9606">human</span>
###xml 791 794 <span type="species:ncbi:10116">rat</span>
###xml 826 829 <span type="species:ncbi:10116">rat</span>
Treatment with 1,25D3 to non-diabetic rats increased body weights but it did not affect any parameter measured in the plasma or urine of these animals, including the plasma levels of calcium, phosphorus and 25-hydroxyvitamin D3. Indeed, we did not detect significant differences in calcium and phosphorus, despite the increases of approximately 30%. In relation to 25-hydroxyvitamin D3 a number of studies [33] has shown that human serum values of 25-hydroxyvitamin D3 were maintained within a normal range across vitamin D supplies from 80 to 1000 IU daily, indicating the existence of an important homeostatic control system regulating human 25(OH)D3 serum concentration. Considering this, in the present study we hypothesize the existence of a similar counter regulatory mechanism in the rat. This mechanism could maintain rat plasma values of 25-hydroxyvitamin D3 within the observed normal range of 15-19 ng/ml, with vitamin D supplies of 150 IU daily administered by injection plus the vitamin D consumed in the diet.
###end p 51
###begin p 52
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 291 296 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 296 298 296 298 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 420 422 420 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 154 158 <span type="species:ncbi:10116">rats</span>
###xml 308 311 <span type="species:ncbi:10116">rat</span>
Treatment with 1,25D3 increased the protein content and the indicator of cell size (protein/DNA) in the kidney, liver, and adipose tissue of non-diabetic rats, although the DNA and RNA content remained unaltered. These increments might indicate hypertrophy. However, although treatment with 1,25D3 increased rat body weights, it did not particularly augment the weight of these tissues. Another explanation is that 1,25D3 might cause hyperplasia. Regarding this, conflicting results have been reported [34,35].
###end p 52
###begin p 53
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 42 44 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 60 64 <span type="species:ncbi:10116">rats</span>
###xml 300 303 <span type="species:ncbi:10116">rat</span>
###xml 345 348 <span type="species:ncbi:10116">rat</span>
We also observed that treatment with 1,25D3 to non-diabetic rats did not affect the expression of any of the two 9.5 and 7.5 Kb IR mRNA species present in kidney, liver, and adipose tissue. Our group and others have previously reported the presence of these species and their relative proportions in rat tissues [21,36]. Since there is only one rat IR gene, variation in transcript length may reflect alternative RNA processing events, such as polyadenylation at different 3' end sites in the final untranslated exon [37].
###end p 53
###begin p 54
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 50 52 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 68 72 <span type="species:ncbi:10116">rats</span>
In addition, we detected that treatment with 1,25D3 to non-diabetic rats affected neither the IR number nor the insulin response in terms of glucose transport in isolated adipocytes from these animals.
###end p 54
###begin p 55
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 28 30 28 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 660 665 660 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 665 667 665 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 706 708 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 741 743 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 875 880 875 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 880 882 880 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 898 899 898 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 900 901 900 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 977 979 977 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 95 99 <span type="species:ncbi:10116">rats</span>
###xml 226 229 <span type="species:ncbi:10116">rat</span>
###xml 364 367 <span type="species:ncbi:10116">rat</span>
###xml 885 890 <span type="species:ncbi:9606">human</span>
###xml 1056 1060 <span type="species:ncbi:10116">rats</span>
The lack of effects of 1,25D3 on IR expression and insulin activity in tissues of non-diabetic rats could be related to the absence of VDR in these tissues. However, both the VDR protein and VDR mRNA have been detected in the rat kidney [38,39] and liver [40,41], and while a VDR-like protein was identified in 3T3-L1 adipose cells [42] VDR mRNA has been found in rat perirenal adipose tissue and 3T3-L1 adipose cells [43]. Another possibility could be the absence of regulation of VDR by its ligand in these tissues. Such lack of regulation has been described in the kidney [39]. In the liver there are no previous data, while in adipose cells treatment with 1,25D3 led to an increase in VDR mRNA levels [43] and a decrease in VDR protein [35]. Regarding this and given our previous experience in determining both VDR protein and VDR mRNA expression and their regulation by 1,25D3 in human cells [6,7], we determined the expression of this receptor and its regulation by 1,25D3 at the protein level in the kidney, liver and adipose tissue of non-diabetic rats. Our results showed a VDR protein only in the kidney (data not shown). More experiments are necessary to confirm this.
###end p 55
###begin title 56
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 31 33 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 68 72 <span type="species:ncbi:10116">rats</span>
Effects of treatment with 1,25D3 to streptozotocin-induced diabetic rats
###end title 56
###begin p 57
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 240 242 240 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 366 368 366 368 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 451 456 451 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 456 457 456 457 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 563 565 563 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 748 749 748 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 814 821 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se </italic>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1025 1027 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 57 61 <span type="species:ncbi:10116">rats</span>
###xml 277 281 <span type="species:ncbi:10116">rats</span>
###xml 403 407 <span type="species:ncbi:10116">rats</span>
###xml 637 641 <span type="species:ncbi:10116">rats</span>
Treatment with 1,25D3 to streptozotocin-induced diabetic rats increased their body weight, but it did not revert the hyperglycemia and the hypoinsulinemia provoked by the streptozotocin. We also detected normal levels of 25-hydroxyvitamin D3 in streptozotocin-induced diabetic rats in accordance with other authors [30]. These unchanged levels of 25-hydroxyvitamin D3 in streptozotocin-induced diabetic rats neither were altered by the treatment with 1,25D3, possibly due to the postulated plasma homeostatic control system that could regulate 25-hydroxyvitamin D3 plasma levels also in the absence of insulin in both groups of diabetic rats. In addition, we observed increased plasma levels of calcium and phosphorus after the treatment with 1,25D3. With regard to these last parameters, it is known that calcium per se is important for insulin secretion, as well as for correction of glucose intolerance [44,45]. Moreover, calcium and phosphorus have been described as regulators of VDR in renal and intestinal tissues [39,46].
###end p 57
###begin p 58
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 20 22 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 276 278 276 278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 49 53 <span type="species:ncbi:10116">rats</span>
Treatment with 1,25D3 to streptozotocin-diabetic rats did not modify the glycosuria and the ketonuria induced by the diabetes, but partially decreased the number of leukocytes in urine. This latter effect could be due to the broadly reported anti-inflammatory effects of 1,25D3 and/or to a possible anti-proliferative effect of this hormone, as observed by our group and others in cell culture [6,33].
###end p 58
###begin p 59
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 39 41 39 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 360 362 360 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 422 424 422 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 76 80 <span type="species:ncbi:10116">rats</span>
###xml 451 455 <span type="species:ncbi:10116">rats</span>
###xml 466 469 <span type="species:ncbi:10116">rat</span>
With respect to tissue effects of 1,25D3 in streptozotocin-induced diabetic rats, we observed the permanence of high protein and DNA content values induced by the diabetes, accompanied by slight increases of the protein/DNA ratio values in the kidney and liver, but not in the adipose tissue. This suggests a certain hypertrophy produced by the action of 1,25D3 in these two tissues. However, although treatment with 1,25D3 to streptozotocin-diabetic rats increased rat body weights, it did not increase the weight of the kidney, liver or adipose tissue. The other explanation, hyperplasia, has conflicting results [33,34].
###end p 59
###begin p 60
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 357 359 357 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 216 219 <span type="species:ncbi:10116">rat</span>
###xml 322 326 <span type="species:ncbi:10116">rats</span>
###xml 394 398 <span type="species:ncbi:10116">rats</span>
The induction of diabetes by streptozotocin did not affect IR mRNA species in the kidney. This finding was not in accord with previous results of increased renal IR mRNA levels, quantified by slot blot, in a similar rat model [22]. This may reflect the failure to alter VDR number in the kidney of streptozotocin-diabetic rats [34]. The treatment with 1,25D3 to streptozotocin-induced diabetic rats neither affected IR mRNA species in the kidney.
###end p 60
###begin p 61
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 478 486 478 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 328 332 <span type="species:ncbi:10116">rats</span>
###xml 572 576 <span type="species:ncbi:10116">rats</span>
Contrarily, streptozotocin produced an important increment in the levels of both IR mRNA species in liver. These findings agree with previous results of increased IR mRNA levels quantified by slot blot [22], Northern blot analysis [21,47] and increased IR gene transcription [21] in the liver of streptozotocin-induced diabetic rats. Streptozotocin also increased the levels of both IR mRNA species in the adipose tissue. This increment represents the first demonstration of an in vivo regulation of IR mRNA levels in the adipose tissue of streptozotocin-induced diabetic rats.
###end p 61
###begin p 62
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 54 56 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 283 285 283 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 473 475 473 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 91 95 <span type="species:ncbi:10116">rats</span>
###xml 446 449 <span type="species:ncbi:10116">rat</span>
###xml 510 514 <span type="species:ncbi:10116">rats</span>
In addition, we observed that the treatment with 1,25D3 to streptozotocin-induced diabetic rats partially prevented the over-expression of IR mRNA induced by the diabetes in the liver and adipose tissue of these animals. The 9.5 Kb IR mRNA species was particularly decreased by 1,25D3 in the liver, and the 7.5 Kb species in the adipose tissue. Therefore, these results provide the first demonstration of an in vivo tissue-specific regulation of rat IR mRNA levels by 1,25D3 in streptozotocin-induced diabetic rats.
###end p 62
###begin p 63
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 47 49 47 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 141 146 141 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 146 148 146 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 217 221 <span type="species:ncbi:10116">rats</span>
A role for VDR in such genomic actions of 1,25D3 in liver and adipose tissue is possible, although to our knowledge the regulation of VDR by 1,25D3 has not yet been studied in these tissues of streptozotocin-diabetic rats.
###end p 63
###begin p 64
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 23 25 23 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 389 390 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 562 567 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 567 568 567 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
The correction by 1,25D3 of the over-expression of IR expression at the RNA level in the liver and adipose tissue of streptozotocin-diabetic animals could represent a beneficial fact of amelioration of the diabetes. In this sense, other facts of amelioration of diabetes were the almost normalization of the number of IRs in adipocytes of streptozotocin-diabetic animals treated with 1,25D3, without alterations in receptor affinity, and the improvement of both basal and insulin-stimulated glucose transport in adipocytes of these diabetic animals treated with 1,25D3.
###end p 64
###begin p 65
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 85 87 85 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 301 310 301 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 341 343 341 343 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 449 450 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 589 594 589 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 594 596 594 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 501 506 <span type="species:ncbi:9606">human</span>
The present in vivo results do not allow to determine whether the prevention by 1,25D3 of the over-expression of IR mRNA induced by the diabetes in liver and adipose tissue of streptozotocin-diabetic animals is due to transcriptional and/or post-transcriptional regulation. Nevertheless, our previous in vitro results demonstrated that 1,25D3 increased IR mRNA levels via mechanisms involving direct transcriptional activation of the human IR gene [5-7]. Moreover, we identified an active VDRE in the human IR gene promoter that accounted for the transcriptional induction of this gene by 1,25D3 in U-937 cells [29].
###end p 65
###begin p 66
###xml 87 92 87 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 92 94 92 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 379 380 379 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 490 492 490 492 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 171 174 <span type="species:ncbi:10116">rat</span>
###xml 350 353 <span type="species:ncbi:10116">rat</span>
Therefore, in support of the possible participation of a transcriptional regulation by 1,25D3 in the present in vivo processes, we have detected by computer search in the rat IR gene promoter two candidate VDREs overlapped by various AP-2-like sites. One VDRE is located between -256 and -219 bp, while the other extends from -653 and -620 bp of the rat IR gene promoter (Figure 4, panel C). Individually or in conjunction, these potential VDREs could form a locus that may respond to 1,25D3 via activation of VDR. This locus may mediate the cross-talk between vitamin D and insulin signalling, although this remains to be determined.
###end p 66
###begin title 67
Conclusion
###end title 67
###begin p 68
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 60 62 60 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 616 621 616 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 621 623 621 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1040 1045 1040 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 1045 1047 1045 1047 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 104 108 <span type="species:ncbi:10116">rats</span>
###xml 164 168 <span type="species:ncbi:10116">rats</span>
###xml 760 763 <span type="species:ncbi:10116">rat</span>
###xml 798 801 <span type="species:ncbi:10116">rat</span>
The present results indicate that while treatment with 1,25D3 had practically no effect on non-diabetic rats, the same treatment in streptozotocin-induced diabetic rats corrected in part the over-expression of the IR gene in liver and adipose tissue, although it did not revert the hyperglycemia, hypoinsulinemia, glycosuria or ketonemia of these diabetic animals. At the same time, it produced normalization of the IR number without alterations in the receptor affinity, but with an improvement of the insulin response in terms of glucose transport in adipocytes of these diabetic animals. These genomic actions of 1,25D3 could represent beneficial facts of amelioration of diabetes via mechanisms, possibly involving direct transcriptional activation of the rat IR gene. A computer search in the rat IR promoter revealed the existence of two candidate vitamin D response element (VDRE) sequences, located at -256/-219 bp and -653/-620 bp and overlapped by three and four AP-2-like sites respectively. These candidate VDREs may respond to 1,25D3 via activation of the vitamin D receptor, although this remains to be investigated.
###end p 68
###begin title 69
Methods
###end title 69
###begin title 70
Animals and sampling
###end title 70
###begin p 71
###xml 435 447 435 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Control-rats</italic>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 518 520 518 520 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 588 593 587 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 593 594 592 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 595 599 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rats</italic>
###xml 750 758 749 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ-rats</italic>
###xml 880 885 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 885 887 884 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 937 940 935 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STZ</italic>
###xml 941 946 939 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1,25D</italic>
###xml 946 947 944 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 948 952 946 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rats</italic>
###xml 20 31 <span type="species:ncbi:10116">Wistar rats</span>
###xml 357 361 <span type="species:ncbi:10116">rats</span>
###xml 443 447 <span type="species:ncbi:10116">rats</span>
###xml 489 493 <span type="species:ncbi:10116">rats</span>
###xml 595 599 <span type="species:ncbi:10116">rats</span>
###xml 631 635 <span type="species:ncbi:10116">rats</span>
###xml 750 753 <span type="species:ncbi:10116">STZ</span>
###xml 754 758 <span type="species:ncbi:10116">rats</span>
###xml 800 804 <span type="species:ncbi:10116">rats</span>
###xml 937 940 <span type="species:ncbi:10116">STZ</span>
###xml 948 952 <span type="species:ncbi:10116">rats</span>
Four groups of male Wistar rats weighing 200-220 g at the onset were used in this study. They were kept under standard conditions of light and temperature and given free access to tap water and standard laboratory chow (Panlab, A04) containing 8.8 mg/g of calcium, 5.9 mg/g of phosphorus and 1.5 IU/g of vitamin D. The first group comprised of non-diabetic rats receiving sham-treatments during the 15 days of the experimental period (Control-rats). The second group included non-diabetic rats i.p. injected with 1,25D3 (Calcijex, Abbot) [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] (1,25D3-rats). The third group consisted of rats rendered diabetic by a single injection of streptozotocin (Sigma) [65 mg/kg] on the 8th day of the 15-day period (STZ-rats). Finally, the fourth group comprised of rats rendered diabetic by streptozotocin on the 8th day, and i.p. injected with 1,25D3 [150 IU/Kg (3.75 mug/Kg) one a day, for 15 days] (STZ+1,25D3-rats). The National Guide for the Care and Use of Laboratory Animals was strictly followed during this study.
###end p 71
###begin p 72
Urine samples were collected before decapitation without anaesthesia and trunk blood samples were recovered for plasma measurements. On sacrifice, the kidney, liver and epididymal adipose tissue were immediately removed, individually packed and frozen in liquid nitrogen for nucleic acid and protein determinations. Isolated adipocytes were obtained from fresh epididymal adipose tissue for insulin binding and insulin activity assays.
###end p 72
###begin title 73
Analytical methods
###end title 73
###begin p 74
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 139 142 <span type="species:ncbi:10116">rat</span>
Different parameters in urine were measured using the Combur Test (Roche). Plasma insulin levels were determined by radioimmunoassay using rat insulin as standard. Plasma concentrations of glucose, 25-hydroxyvitamin D3, calcium, phosphorus and proteins were estimated using commercially available techniques. The total DNA and RNA contents of the homogenates from individual tissues were estimated by spectrofluorometry. The protein content was determined by the Bradford method.
###end p 74
###begin title 75
RNA blot assays
###end title 75
###begin p 76
###xml 195 197 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 432 434 431 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 631 633 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 465 468 <span type="species:ncbi:10116">rat</span>
For Northern blot assays, RNA samples (40 mug) of kidney, liver and epididymal adipose tissue, were denatured, electrophoresed in 1.1% agarose-formaldehyde gels and blotted onto nylon membranes [36]. Ethidium bromide staining of the 28S and 18S ribosomal RNAs was routinely checked before blotting as a control of sample loading and after blotting as a control of RNA transfer. RNA blots were prehybridized, hybridized with excess [32P]-labelled probe (the 0.98-Kb rat IR specific EcoR1 fragment of the p16 clone, gift from Prof. Goldstein), washed under stringent conditions and finally autoradiographed, as described previously [36]. The autoradiographs were scanned with a laser densitometer and the readings normalized with the respective amounts of 28S rRNA, as revealed by ethidium bromide.
###end p 76
###begin title 77
Insulin binding assays
###end title 77
###begin p 78
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 202 205 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">125</sup>
###xml 225 228 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-9 </sup>
###xml 317 321 310 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-10 </sup>
###xml 332 335 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7 </sup>
###xml 430 433 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7 </sup>
###xml 789 791 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
Binding assays were carried out as described previously [48]. In brief, isolated adipocytes (0.25 x 106 cells/ml) were incubated at 30degreesC for 30 min in 400 mul Krebs-Hepes buffer pH 7.6 with mono-[125I]-insulin (0.2 x 10-9 M) (NEN Life Sciences), in the presence or absence of increasing concentrations (0.2 x 10-10 to 0.5 x 10-7 M) of unlabelled insulin (Sigma). Non-specific binding was determined in the presence of 1 x 10-7 M unlabelled insulin and subtracted from each point. The adipocyte number was determined with a Neubauer-type hemocytometer and cell viability (assessed by 0.2% trypan blue exclusion) was greater than 90%. Measurements of the cell diameter were also performed. The data were analysed by the Scatchard method using the LIGAND program of Munson and Rodbard [49].
###end p 78
###begin title 79
Glucose transport determinations
###end title 79
###begin p 80
###xml 86 88 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 389 391 389 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7 </sup>
###xml 439 441 439 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 538 541 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-8 </sup>
###xml 604 605 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
Glucose transport was measured in isolated adipocytes by determining the uptake of D-[14C(U)]-glucose (NEN Life Sciences) at trace concentrations using our modification of the method of Kashiwagi et al. [50]. This method is based on the premise that glucose uptake provides a measure of glucose transport when studies are carried out at very low glucose concentrations. In brief, 0.25 x 106 adipocytes/ml were incubated with 5 x 10-7 M D-[14C(U)]-glucose for 1 h at 37degreesC in the presence and absence of a concentration of insulin (10-8 M) that gave maximal glucose transport in earlier experiments [6]. Assays were stopped by washing the cells with ice-cold PBS. The cells were solubilized in 0.5% SDS and 0.1 N NaOH and the associated radioactivity was counted.
###end p 80
###begin title 81
###xml 42 45 <span type="species:ncbi:10116">rat</span>
Computer analysis of DNA sequences in the rat IR gene promoter
###end title 81
###begin p 82
###xml 52 70 52 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rattus norvegicus </italic>
###xml 138 148 138 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 325 335 325 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 338 344 338 344 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GGGTCA</bold>
###xml 347 353 347 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">GGGGCA</bold>
###xml 463 464 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 503 513 503 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 530 537 530 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PuGGTCA</bold>
###xml 541 548 541 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PuGTTCA</bold>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 752 762 752 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 801 811 801 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">consensus </italic>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 52 69 <span type="species:ncbi:10116">Rattus norvegicus</span>
The identification of virtual VDRE sequences in the Rattus norvegicus partial IR promoter [GenBank:] was carried out by homology with two consensus VDRE sequences using the SEQFIND programme developed in our laboratory and previously employed in the computer analysis of various DNA sequences including VDREs [29]. The first consensus (5'GGGTCANNGGGGGCA3') had been compiled and reported by us from a series of described functional VDRE sequences in various 1,25D3-stimulated promoters [29]. The second consensus VDRE sequence (5'PuGGTCANNPuPuGTTCA3') had been proposed by Colnot et al. [27], and Haussler et al. [26]. The presence of AP-1 and AP-2 sites flanking or overlapping the potential VDREs were identified by their homology with the AP-1 site consensus (5'TGAC/GTCA3') [31] and the AP-2 site consensus (5'GCCN3GGG3') [32] respectively, also using the SEQFIND programme.
###end p 82
###begin title 83
Statistical analysis
###end title 83
###begin p 84
###xml 159 160 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Unless otherwise indicated, the data are expressed as the mean +/- SEM. A comparison between the groups was carried out using the two-tailed, unpaired Student t-test and/or ANOVA comparison, as appropriate. Differences were considered statistically significant when p < 0.05.
###end p 84
###begin title 85
List of abbreviations
###end title 85
###begin p 86
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 141 144 <span type="species:ncbi:10116">STZ</span>
1,25D3: 1,25-dihydroxyvitamin D3; IR: insulin receptor; VDR: vitamin D receptor; RXR: retinoid x receptor; VDRE: vitamin D response element; STZ: streptozotocin.
###end p 86
###begin title 87
Authors' contributions
###end title 87
###begin p 88
###xml 197 200 <span type="species:ncbi:10116">rat</span>
CC conceived the concept and design of the study, carried out the binding and activity studies, analyzed the computer data of DNA sequences and provided drafting of the article. BM carried out the rat models and the determinations in plasma and urine of these animals and performed the RNA blot assays. She also supplied statistical expertise, collected and assembled the data. MG-A participated in the identification by computer analysis of potential VDRE sequences and provided computer support. All authors read and approved the final manuscript.
###end p 88
###begin title 89
Acknowledgements
###end title 89
###begin p 90
###xml 65 68 <span type="species:ncbi:10116">rat</span>
We are most grateful to Prof. B. J. Goldstein, for providing the rat IR cDNA probe. This work was supported by Funds from the Comunidad de Madrid/Universidad Complutense (14134/2005) and the Ministerio de Sanidad y Consumo (P1061744/2006).
###end p 90
###begin article-title 91
###xml 78 81 <span type="species:ncbi:10116">rat</span>
Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas
###end article-title 91
###begin article-title 92
Vitamin D physiology
###end article-title 92
###begin article-title 93
Vitamin D deficiency inhibits pancreatic secretion of insulin
###end article-title 93
###begin article-title 94
###xml 22 24 22 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 62 64 62 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 118 121 <span type="species:ncbi:10116">rat</span>
Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on the novo insulin biosynthesis in the islets of the rat endocrine pancreas
###end article-title 94
###begin article-title 95
###xml 37 39 37 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 122 127 <span type="species:ncbi:9606">human</span>
The effect of 1,25-dihydroxyvitamin D3 on insulin binding, insulin receptor mRNA levels, and isotype RNA pattern in U-937 human promonocytic cells
###end article-title 95
###begin article-title 96
###xml 38 40 38 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 129 134 <span type="species:ncbi:9606">human</span>
Stimulation by 1,25 dihydroxyvitamin D3 on insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells
###end article-title 96
###begin article-title 97
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3
###end article-title 97
###begin article-title 98
###xml 85 89 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice
###end article-title 98
###begin article-title 99
###xml 23 25 23 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 51 55 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
1,25-dihydroxyvitamin D3 prevents insulitis in NOD mice
###end article-title 99
###begin article-title 100
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 41 45 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3
###end article-title 100
###begin article-title 101
Vitamin D and diabetes
###end article-title 101
###begin article-title 102
###xml 98 102 <span type="species:ncbi:10116">rats</span>
Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats
###end article-title 102
###begin article-title 103
###xml 131 135 <span type="species:ncbi:10116">rats</span>
Studies on islet cell regeneration, hyperplasia and intrainsular cellular interrelation in long lasting streptozotocin diabetes in rats
###end article-title 103
###begin article-title 104
###xml 68 72 <span type="species:ncbi:10116">rats</span>
Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy
###end article-title 104
###begin article-title 105
###xml 80 84 <span type="species:ncbi:10116">rats</span>
Insulin binding and glucose metabolism in adipocytes of streptozotocin-diabetic rats
###end article-title 105
###begin article-title 106
###xml 84 88 <span type="species:ncbi:10116">rats</span>
Insulin binding and degradation by kidney cell membranes of streptozotocin-diabetic rats
###end article-title 106
###begin article-title 107
Effect of experimental diabetes on insulin binding by renal basolateral membranes
###end article-title 107
###begin article-title 108
###xml 88 92 <span type="species:ncbi:10116">rats</span>
Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats
###end article-title 108
###begin article-title 109
###xml 131 134 <span type="species:ncbi:10116">rat</span>
Effects of streptozotocin-induced diabetes on insulin binding, glucose transport, and intracellular glucose metabolism in isolated rat adipocytes
###end article-title 109
###begin article-title 110
Impaired insulin binding in isolated adipocytes in experimental diabetic ketoacidosis
###end article-title 110
###begin article-title 111
###xml 10 13 <span type="species:ncbi:10116">STZ</span>
###xml 122 125 <span type="species:ncbi:10116">rat</span>
Effect of STZ-induced diabetes and fasting on insulin receptor mRNA expression and insulin receptor gene transcription in rat liver
###end article-title 111
###begin article-title 112
###xml 55 59 <span type="species:ncbi:10116">rats</span>
###xml 65 68 <span type="species:ncbi:10116">STZ</span>
Tissue-specific regulation of insulin receptor mRNA in rats with STZ-induced diabetes mellitus
###end article-title 112
###begin article-title 113
###xml 48 51 <span type="species:ncbi:10116">rat</span>
Regulation of insulin receptor mRNA splicing in rat tissues. Effect of fasting, aging and diabetes
###end article-title 113
###begin article-title 114
A unified nomenclature system for the nuclear receptor superfamily
###end article-title 114
###begin article-title 115
Vitamin D receptor: New assignments for an already busy receptor
###end article-title 115
###begin article-title 116
The nuclear vitamin D receptor: biological and molecular regulatory properties revealed
###end article-title 116
###begin article-title 117
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 72 73 72 73 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Identification of DNA sequences that bind retinoid x receptor-1,25(OH)2D3-receptor heterodimers with high affinity
###end article-title 117
###begin article-title 118
Vitamin D receptor interactions with positive and negative DNA response elements: an interference footprint comparison
###end article-title 118
###begin article-title 119
###xml 54 59 <span type="species:ncbi:9606">human</span>
Identification of a vitamin D response element in the human insulin receptor gene promoter
###end article-title 119
###begin article-title 120
###xml 100 104 <span type="species:ncbi:10116">rats</span>
1,25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats
###end article-title 120
###begin article-title 121
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements
###end article-title 121
###begin article-title 122
Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control
###end article-title 122
###begin article-title 123
Vitamin D and genomic stability
###end article-title 123
###begin article-title 124
###xml 79 83 <span type="species:ncbi:10116">rats</span>
Vitamin D receptors in intestine, kidney and thymus of streptozotocin diabetic rats
###end article-title 124
###begin article-title 125
1,25-Dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation
###end article-title 125
###begin article-title 126
###xml 81 85 <span type="species:ncbi:10116">rats</span>
Tissue-specific modulation of insulin receptor mRNA levels in adrenaline-treated rats
###end article-title 126
###begin article-title 127
Posttranscriptional mechanism account for differences in steady state levels of insulin receptor messenger RNA in different cells
###end article-title 127
###begin article-title 128
###xml 40 42 40 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 51 53 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 65 69 <span type="species:ncbi:10116">rats</span>
Homologous up-regulation of the 1,25(OH)2 vitamin D3 receptor in rats
###end article-title 128
###begin article-title 129
Distinct, tissue specific regulation of vitamin D receptor in the intestine, kidney, and skin by dietary calcium and vitamin D
###end article-title 129
###begin article-title 130
###xml 50 52 50 52 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 73 76 <span type="species:ncbi:10116">rat</span>
Tissue distribution of the 1,25-dihydroxyvitamin D3 receptor in the male rat
###end article-title 130
###begin article-title 131
Novel and sensitive detection systems for the vitamin D receptor-in situ-reverse transcriptase-polymerase chain reaction and immunogold cytochemistry
###end article-title 131
###begin article-title 132
Demonstration of 1 alpha, 25-dihydroxyvitamin D3 receptor-like molecule in ST13 and 3T3L1 preadipocytes and its inhibitory effects on preadipocyte differentiation
###end article-title 132
###begin article-title 133
Vitamin D receptor gene expression is up-regulated by 1,25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes
###end article-title 133
###begin article-title 134
###xml 79 82 <span type="species:ncbi:10116">rat</span>
Calcium homeostasis in chronic streptozotocin-induced diabetes mellitus in the rat
###end article-title 134
###begin article-title 135
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo
###end article-title 135
###begin article-title 136
###xml 114 117 <span type="species:ncbi:10116">rat</span>
Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat
###end article-title 136
###begin article-title 137
###xml 45 49 <span type="species:ncbi:10116">rats</span>
Treatment of streptozotocin-induced diabetic rats with vanadate and phlorizin prevents the over-expression of the liver insulin receptor gene
###end article-title 137
###begin article-title 138
###xml 53 57 <span type="species:ncbi:10116">rats</span>
Insulin binding and action on adipocytes from female rats with experimentally induced chronic hyperprolactinemia
###end article-title 138
###begin article-title 139
LIGAND: a versatile computerized approach for characterization of ligand-binding systems
###end article-title 139
###begin article-title 140
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
In vitro insulin resistance of human adipocytes isolated from subjects with noninsulin-dependent diabetes mellitus
###end article-title 140

